ICPA Health Products—a pharmaceutical company, has launched Wet Mouth, a saliva substitute for treating individuals suffering from xerostomia or commonly known as dry mouth.
ICPA in a statement said that Wet Mouth contains Sodium Carboxymethyl Cellulose is a pleasantly flavoured base that helps enhance oral lubrication in the mouth and is an easy solution to overcome a dry mouth.
“Regular use of Wet Mouth keeps the oral mucosa moist and lubricated. It reduces surface abrasion which helps patients eat, swallow and speak comfortably. Every 5 ml of Wet Mouth contains Sodium Carboxymethyl cellulose 0.5% w/v and Glycerine 30% w/v,” ICPA claimed.
According to ICPA, one in every five individuals in the world suffers from dry mouth or xerostomia.
It occurs when the salivary glands are not able to produce enough saliva to keep the mouth wet.
A dry mouth can cause difficulties in performing essential life activities such as tasting, chewing, swallowing, and speaking.
From the oral health point of view, it can increase the risk of developing cavities, tooth sensitivity, oral infections, and mouth sores.
Dry mouth is found more commonly among older individuals due to a greater prevalence of medical conditions such as diabetes mellitus and many autoimmune diseases.
Also, more than a hundred medications and cancer therapy are associated with salivary gland dysfunction leading to dry mouth.
Xerostomia or dry mouth affects approximately 22 percent of the global population.